Literature DB >> 18235859

Deconstructing and reconstructing illness syndromes associated with psychosis.

William T Carpenter1.   

Abstract

Entities:  

Year:  2007        PMID： 18235859      PMCID： PMC2219902     

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  8 in total

1.  A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia.

Authors:  Robert W Buchanan; Miriam Davis; Donald Goff; Michael F Green; Richard S E Keefe; Andrew C Leon; Keith H Nuechterlein; Thomas Laughren; Robert Levin; Ellen Stover; Wayne Fenton; Steve R Marder
Journal:  Schizophr Bull       Date:  2005-02-16       Impact factor: 9.306

2.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

3.  Deficit and nondeficit forms of schizophrenia: the concept.

Authors:  W T Carpenter; D W Heinrichs; A M Wagman
Journal:  Am J Psychiatry       Date:  1988-05       Impact factor: 18.112

Review 4.  A separate disease within the syndrome of schizophrenia.

Authors:  B Kirkpatrick; R W Buchanan; D E Ross; W T Carpenter
Journal:  Arch Gen Psychiatry       Date:  2001-02

5.  The two-syndrome concept: origins and current status.

Authors:  T J Crow
Journal:  Schizophr Bull       Date:  1985       Impact factor: 9.306

6.  The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs.

Authors:  J S Strauss; W T Carpenter; J J Bartko
Journal:  Schizophr Bull       Date:  1974       Impact factor: 9.306

Review 7.  Strong inference, theory testing, and the neuroanatomy of schizophrenia.

Authors:  W T Carpenter; R W Buchanan; B Kirkpatrick; C Tamminga; F Wood
Journal:  Arch Gen Psychiatry       Date:  1993-10

8.  Negative v positive schizophrenia. Definition and validation.

Authors:  N C Andreasen; S Olsen
Journal:  Arch Gen Psychiatry       Date:  1982-07
  8 in total
  8 in total

Review 1.  Decision-making, behavioral supervision and learning: an executive role for the ventral premotor cortex?

Authors:  C Acuña; J L Pardo-Vázquez; V Leborán
Journal:  Neurotox Res       Date:  2010-04-20       Impact factor: 3.911

2.  Chromosome 13q13-q14 locus overlaps mood and psychotic disorders: the relevance for redefining phenotype.

Authors:  Michel Maziade; Yvon C Chagnon; Marc-André Roy; Alexandre Bureau; Alain Fournier; Chantal Mérette
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

3.  From Perception to Thought: A Phenomenological Approach to Hallucinatory Experience.

Authors:  Andrea Raballo
Journal:  Schizophr Bull       Date:  2016-11-21       Impact factor: 9.306

Review 4.  The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European psychiatric tradition.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

5.  The genetics of symptom-based phenotypes: toward a molecular classification of schizophrenia.

Authors:  Pamela DeRosse; Todd Lencz; Katherine E Burdick; Samuel G Siris; John M Kane; Anil K Malhotra
Journal:  Schizophr Bull       Date:  2008-07-15       Impact factor: 9.306

Review 6.  Systematic of psychiatric disorders between categorical and dimensional approaches: Kraepelin's dichotomy and beyond.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

7.  Deficit schizophrenia: an update.

Authors:  Brian Kirkpatrick; Silvana Galderisi
Journal:  World Psychiatry       Date:  2008-10       Impact factor: 49.548

8.  Rediscovering psychopathology: the epistemology and phenomenology of the psychiatric object.

Authors:  Josef Parnas; Louis A Sass; Dan Zahavi
Journal:  Schizophr Bull       Date:  2012-12-23       Impact factor: 9.306
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.